BridgeMD
New treatment option for Elbow Fracture
Official title Management of Type 1 Supracondylar Humeral Fractures
ClinicalTrials.gov ID: NCT04642807
What this study is testing
- What it's testing
- This study compares the clinical outcomes of treating pediatric Type 1 supracondylar fracture with a long arm soft cast and no clinical or radiographic follow-up versus the standard treatment in a long arm cast with clinical follow-up. This is the first multicenter randomized control trial looking at the clinical effectiveness, safety and parental satisfaction of managing inherently stable Type I supracondylar fractures without clinical or radiological follow-up.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 8. Healthy volunteers may be eligible.
You may be able to join if
- \- Children 3 to 8 years of age with a diagnosed supracondylar humerus fracture Type 1 (undisplaced).
You likely can't join if
- Children diagnosed with a Type II or III supracondylar fracture or any other elbow injury
- Children who present with neurovascular compromise associated with their fracture
- Children who have been previously diagnosed with a metabolic or structural bone disease that predisposes them to fractures Diagnostic criteria for a...
The study team makes the final eligibility decision.
Where it's taking place
- South Brisbane, Australia
- Vancouver, British Columbia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 8 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include South Brisbane, Australia; Vancouver, British Columbia, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.